flymetothemoon
1,000+ Views

How your body reacts to Coca Cola

What does Coca Cola do to your body? Everyone knows that coca cola is bad for your body, but why? The best way to stop doing bad for your body, or help someone from doing it, is to help them understand why it is not good for them. So with that in mind, this is what happens to your body when you drink Coca Cola: After 10 minutes - 10 tea spoons for sugar (1 glass of Coke) and phosphoric acid (corrosive but diluted in cola) will cause strike the body. After 20 minutes - Insulin levels make a big jump. The liver converts all the sugar into fat. After 40 minutes - Caffeine is completely ingested. Eye pupils expand. Blood pressure rises because liver pushes more sugar into the bloodstream. The adenosine receptors, however get blocked thus preventing drowsiness. After 45 minutes - Body raises production of dopamine hormone, which stimulates the brain pleasure center. This is basically what Heroin does. After 1 hour - Phosphoric acid binds calcium, magnesium, and zinc in the gastrointestinal tract, which supercharges the metabolism. Furthermore, the body expels more calcium than average through urine. After more than 1 hour - The diuretic effect (the elimination of salt and water from the body) of the drink starts. Along with sodium, calcium, magnesium, and zinc are also removed via urine. By this time, one may already be feeling irritable. So that is the actual breakdown of what your body really does once the coke is in your body. Too often, we say this is bad for you or this is good for you, but I always wonder "why is it?” This is why coca cola (or any other soda really) is bad for your body. You can make the decision whether it is bad enough for you to actually stop drinking it.
18 Likes
2 Shares
6 Comments
Suggested
Recent
@flymetothemoon Well...this article is all kinds of wrong. 1) Phosphoric acid is found in tons of things, including MILK. Are you going to tell me milk is bad? 2) The liver doesn't convert sugars straight to fat. The body converts complex sugars (polysaccharides) into short and simple sugars (monosaccharides), such as glucose. Your body literally uses glucose for energy. You can't survive without. Yes, excess sugars in the liver will eventually be converted to fats. 3) Caffeine is not bad for you, and the way your writing about it is a scare tactic. Coke Classic has 38mg per 12oz, the amount of caffeine needed to feel anxiety, insomnia, rapid heart and respiration rate increase is 500+ mg. So like 13 cans of Coke. 4) Not only does your body release dopamine, dopamine, acetylcholine, serotonin, and, in high doses, on norepinephrine. These some of the most common chemicals in the body. Dopamine is released for almost everything, even for feelings of love and affection. So now milk, love, coke and heroin are all on the same level? 5) This is mish-mosh mumbo jumbo. Phosphorous, which phosphoric acid is a derivative of, helps the body speed up the absorption of calcium. It literally helps your body hold onto it. 6) Almost everything has a diuretic effect on the body. Almost every food ever prepared has salt (aka sodium chloride) in it. So maybe we should just stop eating all together. The truth is pretty much everything is okay, in moderation. You aren't going to die if you have a Coke every once in awhile.
I don't drink soda because I don't like carbonation, but it looks like I'm not missing out on anything!
@BikeSnob can I just huzzah your comment?
oh wow @onesmile me too! like you said i just knew coke was bad but calcium exiting your body?? did you know in some country it was proven that coke can actually be used to remove blood stain on the streets when there are accidents... just thinking about that make me want to stop drinking coke for the rest of my life!
@BikeSnob @onesmile Well then, that was, well. Jeez man that's a lot of writing. Lolol!
Cards you may also be interested in
Cell Counting Market - Trends, Growth and Future Analysis
The market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.  The medical application segment will grow at the highest CAGR in the cell counting market. Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment during the forecast period.  The high growth of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical RD expenditure, and commercial expansion of various pharmaceutical companies.  For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728 The large growth of this segment can be attributed to factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization.  The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US). 
Real World Evidence Are Used To Monitor The Post Market Safety and Adverse Events of Drugs
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be very helpful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while helping to organize and evaluate clinical data for regulatory submissions. The uncertainty brought on by the COVID-19 pandemic has dramatically shifted how and when patients decide to seek medical care. In addition, shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes.   RWE is set to become the most influential emerging technology to help in the fight against the COVID-19 outbreak, according to the latest poll on GlobalData’s Pharmaceutical Technology website. In this poll, which was completed by 935 of its readers in April 2021, more than one-third of the respondents indicated that RWE would have the greatest impact on the management of COVID-19.  Even though emerging technologies, such as telemedicine, have existed for decades, most of healthcare systems rely heavily on in-person interactions between patients and clinicians. Nevertheless, the current requirement for social distancing measures is swiftly pushing the primary care provision toward remote care. Telemedicine and virtual care may also prompt a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991 The utilization of RWE in infectious disease control is not a new concept. During the Ebola outbreak in 2014, forecasters successfully used Global Epidemic and Mobility (GLEaM) simulations that combined real-world data on populations and their mobility with rigorous stochastic models of disease transmission to predict the global spread of the disease.  In countries with strict data privacy laws, the implications of contact-tracing apps on individual privacy are considered a major associated concern. While cryptographers are currently working on improving tracing apps to address the issue, tracking apps can only be effective when they are used by a significant proportion of the population. Therefore, it is critical that the functionality and safety of these applications are considered acceptable by the majority of the population.  Through the analysis of the data generated from various networks, healthcare organizations can benefit from sensible information, resulting in real-time disease monitoring and control. However, as the use of technology as a means to produce more and more data to drive insights and foresight increases, the ability to automate and analyze that data becomes a necessity. Accelerated digitalization in the healthcare space has revealed gaps in infrastructure, workforce, and digital education that ultimately need to be bridged.   Real World Evidence Solutions Market Dynamics Without intelligent analytics, RWE alone will not be able to produce meaningful and actionable results. Previously, the healthcare industry did not have the ability to gather RWE at the speed and scale needed to address urgent public health crises. However, this scenario has changed due to the pandemic. Advances in analytics and access to broad and diverse real-world data sets have made it possible to rapidly analyze data as it is captured to better understand how pandemics like COVID-19 are unfolding.  The pre-approved use of RWE in efficacy decisions is being carried out currently, and there is potential for it to be used more broadly, such as in oncology, rare diseases, and pediatric conditions when randomized controlled clinical trials are impossible or unethical to conduct. In parallel, legislators are recognizing the value of RWE. In the US, the 21st Century Cures Act, passed in December 2016, has established public-private partnerships to collect data and improve the understanding of diseases. 
Covid-19 Impact and Future Scenario For Medical Ceramics - Research, Future Analysis
The global spread of COVID-19 has led to the complete suspension of elective surgeries, especially in the most affected countries. Some regions witnessed a 70% reduction in the number of patients seeking aesthetic treatments from January 2020 onwards. Moreover, several dental events have been postponed due to the COVID-19 pandemic.  For instance, KRAKDENT 2020, the largest dental show in Poland and an event that attracts over 15,000 visitors worldwide has been rescheduled. The CEO of Straumann Group announced that the COVID-19 outbreak was expected to reduce sales in the Asia Pacific in FY 2020 by at least USD 31 million. Additionally, DENTSPLY Sirona recently predicted that its sales in the Chinese, South Korean, Taiwanese, and Japanese markets would fall by a cumulative USD 60–70 million in FY 2020.   Medical implants are artificial devices that are used to replace damaged or missing biological parts. Implants help deliver medication, monitor body functions, and provide support to organs and tissues in different applications (such as dental, orthopedic, and cardiovascular).   The medical implants market is driven by the growing healthcare needs of the senior population, advancements in medical technologies, and the rising incidence of chronic diseases, such as osteoarthritis, cardiovascular diseases, neuropathic diseases, and congenital disorders, among others.  The significant growth in the geriatric population is expected to result in an increased demand for joint reconstruction, cardiovascular surgeries, and dental replacement procedures and an increase in the prevalence of hearing loss. These factors are, in turn, expected to support the growth of the hearing, orthopedic, and dental implants market.  For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129 Medical ceramics are key components in the manufacturing of various implantable devices, such as orthopedic implants (artificial hips, knee, shoulder, wrists, fracture fixation, and bone grafts), cardiovascular implants (heart valves, pacemakers, catheters, grafts, and stents), dental implants (enamels, fillings, prosthetics, and orthodontics), and hearing implants (cochlear implants).  Considering the growing demand for implantable devices in different segments (such as cardiovascular, dental, and orthopedics), the uptake of medical ceramics is expected to increase in the coming years.  These products have to be implanted inside the human body; they need to be biocompatible and comply with the ISO biocompatibility testing standards. However, it is difficult to anticipate the biocompatibility till the later stages of clinical trials, making companies and investors apprehensive of investing in this market.  Also, regulatory procedures are complicated, restrictive, and depend on the composition of ceramics and their future applications, making the approval process for medical ceramic products cumbersome, expensive, and time-consuming. These factors are expected to hinder the growth of the medical ceramics market to a certain extent.  The World Economic Forum estimates these emerging economies to account for around one-third of the global healthcare expenditure by 2020. The rising geriatric population in these countries will lead to increased demand for medical facilities and devices, which is likely to propel the growth of the medical ceramics market. Moreover, growth in these markets can primarily be attributed to the low prices of dental treatments in these countries compared to developed economies and their infrastructural development.   Additionally, medical device manufacturers are also setting up their facilities in the Asia Pacific, the Middle East, and Latin America. In recent years, key players such as Baxter International, Becton Dickinson, BIOTRONIK, Hoya Surgical Optics, Life Technologies, Medtronic, Siemens Medical Instruments, and AB SCIEX have set up their manufacturing and RD facilities in Singapore.  The lack of a skilled workforce and proper techniques to repair further highlight the issue of reparability. Medical ceramics have a long lifespan but are not recyclable. Due to the long lifespan and various mechanical and optical properties of medical ceramics, the different composites used in various end-use applications face recyclability and reparability. This is one of the major challenges hampering the growth of the medical ceramics market.  The medical ceramics market in Asia Pacific, particularly in China, Japan, and India, is expected to witness high growth in the coming five years. The medical ceramics market in the APAC is estimated to grow rapidly during the forecast period, considering the development of the region's healthcare sector. The major consumers of medical ceramics in the APAC are China, South Korea, and Japan.
What A Coke Does To Your Body In 1 Hour
I'll be the first to admit that I love Coca Cola. But it's absolutely horrible for us. A very detailed infographic supplied by TheRenegadePharmacist.com has officially proven again how bad Coke is for your body (WE KNOW). The American CDC has said that 25% of Americans drink soda on a regular basis which is a hefty reason why obesity has run rampant. Sugar is the main culprit since an average can of soda can contain 3 tablespoons of sugar and 4 tablespoons if in a 12-ounce-bottle. Coke is one of the most popular soft drinks in the United States with a massive marketing empire so there will never be a day where we won't see it somewhere. But there comes a time where you need to take a moment and see what you're putting into your body. Let's take a look : All it takes is ONE Coke : First 10 Minutes : 10 teaspoon of sugar hit your system. (100% of your recommended daily intake.) You don't immediately vomit from the overwhelming sweetness because phosphoric acid cuts the flavor allowing you to keep it down. In 20 Minutes : Your blood sugar spikes, causing an insulin burst. Your live responds to this by turning any sugar it can get its hands on into fat. (There's plenty of that at this particular moment.) In 40 Minutes : Caffeine absorption is complete. Your pupils dilate, your blood pressure rises, as a response your liver dumps more sugar into your bloodstream. The adenosine receptors in your brain are now blocked preventing drowsiness. In 45 Minutes : Your body ups your dopamine production stimulating the pleasure centers of your brain. This is physically the same way heroin works, by the way. In 60 Minutes : The phosphoric acid binds calcium, magnesium, and zinc in your lower intestine providing a further boost in metabolism. This is a compounded by high doses of sugar and artificial sweeteners also increasing the urinary excretion of calcium. After 60 Minutes : The caffeine's diuretic properties come into play. (It makes you have to pee.) It is now assured that you'll evacuate the bonded calcium, magnesium, and zinc that was headed to your bones as well as sodium, electrolyte and water. As the rave inside of you died down you'll start to have a sugar crash. You may become irritable and/or sluggish. You've also now, literally, pissed away all the water that was in theCoke. But not before infusing it with valuable nutrients your body could have used for things like having the ability to hydrate your system of build strong bones and teeth. Why you should care? - Coke weakens bones and teeth. - Increases your chance for getting diabetes. - It slows your metabolism, especially long term. - Aspartame in the soda leads to disease and organ irritation. - Coke has negative affects on fertility. - It leads to weight gain. - Can worsen asthma or increase risk for heart disease. - Cancer, Osteoporosis, and Kidney issues are common in people who drink soda. - It's expensive to continually buy it. - Diet sodas are a scam and false advertising. All soda is bad for you. - No nutritional value. - Raised cholesterol and specifically increased belly fat. Do I need to say more? Coke or soda for that matter is never a good idea. (But don't worry, I still love it.)
Health Agency Releases 'Anti Coca-Cola' Ad, But Are They Making Assumptions?
Americans have been drinking Coca-Cola for well over a century. We've been enjoying it during baseball games, in our pizza parlors, at the movies, and even in mixed cocktails for many generations. But as obesity rates - and the illnesses associated - hit a record high, many health advocates have been taking proactive strides to create change. In comes 'Change The Tune', a public service advertisement funded by the Center for Science in the Public Interest (CSPI), a national watchdog group. Adapted from Coca-Cola's iconic 'Hilltop' campaign, the ad focuses on the detrimental effects of drinking sugary beverages like Coca-Cola. But instead of singing that they'd 'like to buy the world a Coke', real-life Americans with a number of different diet-induced medical conditions sing a cautionary tale in a very dark manner, complete with a 'Truth' campaign style shot of a Diabetes 2 patient injecting insulin into his stomach. While I understand the obesity crisis in this country is something we must take control over, does anyone else feel like this ad is making a lot of sweeping generalizations about people who have these kinds of conditions? Granted, nutrition is a HUGE factor, but specifically calling out soda and making implications that soda alone caused these people to acquire their medical conditions is a little much. To conclude that sugary beverages are the only reason people acquire Diabetes 2, hypertension, tooth decay, or obesity (they LITERALLY write 'fighting soda-related obesity') is to suspend everything we have learned about human genetics. For starters, Diabetes 2 has been stigmatized as a 'fat person' condition, when in all actuality, it is a highly genetic condition that affects Native Americans, African Americans, and Hispanics at a proven and disproportionate rate. While diet can play a factor, of course, it is certainly not always the case for everyone. The same argument could be made for obesity. Now, you can easily gain weight if you take more calories in than you expel, but research has also shown that metabolism ranges greatly from person to person. And surely, when someone is overweight, it would be pretty impossible to pinpoint something as specific as soda as the cause. (That's like those people who omit baby carrots from their diet because they read somewhere it causes cancer. Many, many factors usually go into why a person's diagnosed with cancer, and I don't think indulging in a 3-ounce bag of baby carrots is going to kill you.) Similar arguments regarding genetics can also be made for hypertension and people prone to tooth decay. (No, seriously, those teeth can fall out from sweets AND genetics). Ultimately, I'm not saying that it isn't possible for unhealthy diet habits to cause certain medical conditions. I'm just saying that pinpointing one specific food and saying "This thing specifically caused this guy's high blood pressure problem!" is like the nutritional equivalent of witch-hunting when the reality is no one really knows any of this for certain. And I know I can't be the only one who feels like this commercial is only fueling the stigma we have against what is popularly perceived as 'fat people conditions'. Moral of the story: Throw out the Coke. But throw out the perpetuation of stereotypes too.
High Healthcare Expenditure To Drive The Growth Of The Operating Room Management Market
The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in cancellations of elective surgeries worldwide. According to a report published by researchers of CovidSurg Collaborative, around 28 million surgeries were canceled across the globe during 12 weeks of peak disruption during the COVID-19 pandemic.   To handle the increased surgical volumes, hospitals are increasing OR hours and focusing on better utilization of OR. The COVID-19 will positively impact the ORM software market. It will increase the adoption rate of ORM software as most hospitals will now focus on increasing capacity by using technology to improve efficiency.  The overall cost of healthcare delivery has grown significantly over the last few decades, mainly due to increasing health insurance premiums, the rising demand for quality healthcare services, the rising geriatric population, and the increasing incidence of chronic disorders.  Another important factor attributing to rising healthcare costs is the high dependency on traditional and outdated methods such as paper-based patient records, which leads to an increase in readmission rates, medical errors, and administration costs.  Different governments and healthcare systems worldwide are now focusing on controlling rising healthcare costs by minimizing patient readmissions, medical errors, and administration costs with the effective utilization of various healthcare IT solutions. Operating rooms or ORs account for 40% of the total hospital expenses and constitute ~70% of the total revenue generated.   For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=175407912 The adoption of ORM solutions has been particularly affected by its high installation and maintenance costs. ORM software, when once installed, also requires to be regularly updated as per the user’s requirement and software enhancements, thereby presenting recurring expenditure. Additionally, the maintenance of high-end IT-enabled systems typically costs more than the software itself.  The annual maintenance cost is estimated to be 20-25% of the initial cost of the software licenses. Subsequently, it can be expected that the high costs incurred from the purchase, installation, maintenance, and upgrade of ORM software and solutions may negatively affect their overall adoption among end-users, thus restraining market growth to a certain extent.  Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. According to the World Economic Forum, these emerging economies will account for around one-third of the global healthcare expenditure by 2020. More than half of the world’s population resides in India and China, owing to which these countries are home to a large patient base. The increasing burden of cancer, improvements in healthcare infrastructure, a less-stringent regulatory environment, and growing medical tourism are encouraging players in the operating room management market to increase their presence in emerging countries. Owing to the expansion of the patient population base, the number of hospitals and surgical centers is also expected to increase in emerging countries in the coming years. Also, currently, governments in these countries are undertaking initiatives to expand and modernize their respective healthcare infrastructures.  The number of independent health care providers has been decreasing as most healthcare providers are turning to mergers, acquisitions, and partnerships and are functioning under a health system rather than operating independently. On a 15-year basis, the percentage of hospitals functioning under a health system has increased from approximately 50% to approximately 65%. Today, over 70% of hospitals are operating as part of a health system rather than independently.  Data management communication solutions accounted for the largest share of the operating room management market in 2019 owing to the benefits such as easy sharing of patient status in perioperative care phases, tracking of the schedule compliance, and sharing of the media and information related to cases within different operating rooms or external hospital departments.  The high growth of this segment can primarily be attributed to advantages such as scalable data storage, scalable computing power, machine-learning capabilities, and faster data transfer between organizations of cloud platforms.
Cleanroom Technology Market to Witness Impressive Growth
The increasing demand in developing economies and the growing focus on energy-efficient cleanrooms are expected to offer significant opportunities for market growth in the coming years. However, the high operational cost associated with the cleanrooms is expected to restrain market growth to a certain extent.  The global health crisis triggered by the COVID-19 pandemic has made it imperative that the pharmaceutical industry moves at a rapid pace alongside researchers, regulators, and contract research companies to develop a diagnosis, treatment, and vaccines. Cleanroom technologies and services play an important role in this scenario to ensure that quality, safety, and efficacy are being maintained.  In the current scenario, the healthcare industry is witnessing an unparalleled demand for diagnostic tests, personal protective equipment (PPE), medical ventilators, and other critical medical supplies. Facing the potentiality of a high risk of infection, healthcare professionals (HCPs) are also facing significant challenges in providing specific and effective care (often remotely).  In Hospital systems are becoming overwhelmed with the rapidly increasing number of COVID-19 patients, which is weighing heavily on the pharmaceutical industry. With the increasing demand for certified products, various quality certifications such as ISO checks and National Safety and Quality Health Standards (NSQHS) have been made mandatory for ensuring that the standards for manufacturing processes and products are being upheld. The quality certifications require products to be processed in a cleanroom environment to ensure minimum possible contamination.   Also, the price per square foot is not the same for ISO 6 and ISO 8 cleanrooms. This is because the amount of air supplied is different in both classes of cleanrooms. The air is 100 times cleaner in an ISO 6 cleanroom than in an ISO 8 cleanroom, thereby doubling the air conditioning capacity of the HVAC systems.   For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482 Cleanrooms are mostly designed according to customer requirements based on product specifications and customer-specific design requirements. However, there are no specific guidelines for cleanroom designs for different application areas or product types. This leads to several challenges for cleanroom manufacturers, as they need to follow different designs every time.  The consumables segment accounted for the larger market share in 2019. The high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing has resulted in the increased adoption of the consumables in the cleanroom technologies market. Also, the large number of RD activities in the healthcare industry is resulting in a stable demand for cleanroom consumables among end-users.   The hardwall cleanrooms segment is expected to witness the highest growth during the forecast period. This is mainly due to the higher demand for hardwall cleanrooms, as they are more design-flexible than standard and softwall cleanrooms, quick and easy to install, freestanding for easy portability, and easy to expand or reconfigure.   This is due to its favorable government regulations, increasing healthcare expenditure, and the growing base of pharma companies in the country, all of which are driving adoption of cleanroom solutions in the Asia Pacific. 
The effect of #CocaCola in 7 steps in 1 hour!
Watch out, you may be hurt! ;) Na zdrowie! Graphic supplied by TheRenegadePharmacist.com. An average can of soda contain 3 tablespoons of sugar and 4 tablespoons if in a 12-ounce-bottle. First 10 Minutes : 10 teaspoon of sugar hit your system. (100% of your recommended daily intake.) You don't immediately vomit from the overwhelming sweetness because phosphoric acid cuts the flavor allowing you to keep it down. In 20 Minutes : Your blood sugar spikes, causing an insulin burst. Your live responds to this by turning any sugar it can get its hands on into fat. (There's plenty of that at this particular moment.) In 40 Minutes : Caffeine absorption is complete. Your pupils dilate, your blood pressure rises, as a response your liver dumps more sugar into your bloodstream. The adenosine receptors in your brain are now blocked preventing drowsiness. In 45 Minutes : Your body ups your dopamine production stimulating the pleasure centers of your brain. This is physically the same way heroin works, by the way. In 60 Minutes : The phosphoric acid binds calcium, magnesium, and zinc in your lower intestine providing a further boost in metabolism. This is a compounded by high doses of sugar and artificial sweeteners also increasing the urinary excretion of calcium. After 60 Minutes : The caffeine's diuretic properties come into play. (It makes you have to pee.) It is now assured that you'll evacuate the bonded calcium, magnesium, and zinc that was headed to your bones as well as sodium, electrolyte and water. As the rave inside of you died down you'll start to have a sugar crash. You may become irritable and/or sluggish. You've also now, literally, pissed away all the water that was in theCoke. But not before infusing it with valuable nutrients your body could have used for things like having the ability to hydrate your system of build strong bones and teeth. #USA #Europe #Europa #infographic #socialmedia #zdrowie #health #food #soda #napoje #cukier #sugar #pressure #blood #cofeine #kofeina #uzaleznienia #uzaleznienie 
(no title)
ラブドールをトラックの助手席に座らせて運ばせる客 そのうえ、新藤さんは緊急事態宣言下の今年春ごろ、とんでもない“荷物”の引越しもさせられている。その荷物とは、人間と見紛うほどリアルなラブドールである。 いったいどういう状況でラブドールを運ぶことになったんですか 新藤 その客は古い2DKのマンションに住む30代前半の小柄な男性で、一見すると物静かな印象でした。荷物の量自体は普通のひとり暮らしの男性と同じだったんですが、奥の3畳ほどの部屋だけは、なぜかガラス戸が固く閉まったままでした。そこでガラス戸を開けると、アンティーク風の椅子が真ん中にあり、髪が長くて肌の白い人形がフェミニンな服を着て座っていたんです。ものすごく高品質かつリアルなダッチワイフで、最初は人間の女性に見えました。作業員が集まって「あれはなんだ」「人?」「いや人形じゃないか」とヒソヒソ相談したくらいです。 ─たしかに最近のラブドールのクオリティはすごいと聞きます。 新藤 でも、大変だったのはそこからでした。通常の手順通り、セックス人形にプチプチを巻いて緩衝材の布をかけようとしたら、男性が血相を変えて「何をしているんですか!!」と僕の手をガッとつかんだんです。「梱包して運ぼうとしているんですが」と答えると、男性は「それは違うでしょ。普通は人にそんなことをしない」と真剣な表情で言う。なるほど。男性にとってそのラブドールドールは「人」であり「彼女」なんですね。 https://www.saikodoll.com/ セックス人形と並んで座り新居まで 新藤 そういうことみたいです。それで先輩を交えて男性と相談した結果、トラックの座席にドールを乗せて移動することになりました。通常の作業時は運転手、先輩、僕の3人で座席に乗って移動するんですが、僕は機材を運搬する別の車両に乗り、代わりにセックス人形を助手席に座らせて、ちゃんと人間のようにシートベルトも着用させて運びました。 先輩はめちゃくちゃ恥ずかしかったそうです。新居までの移動時間が1時間あまり。その間、作業着姿のおじさん2人がラブドールと並んで座り、ほかのドライバーからジロジロ見られ続けたわけですから。そういう意味では、この男性は本当に迷惑な客でした。
The Importance of Bioprocess Containers - Research News
The growth of single-use technologies can be attributed to the growing need for better, cheaper, and faster biologics production. Active development of individualized biologics and personalized medicines, including patient-specific cellular gene therapies and therapeutic vaccines, demands high sterility and is therefore manufactured using single-use equipment and consumables.   In recent years, more biologics having higher potency that require smaller production volumes, advancements in biosimilars targeting smaller markets, and ongoing improvements in production yields and efficiencies that create production operations at much smaller scales have increased the use of single-use technologies such as single-use bioprocess containers/bags as they are best suited for small volume productions. However, single-use technologies are now slowly moving towards clinical production and commercial operations. In 2020, the US FDA approved 53 new medicines and therapeutic biologics (Source: US FDA). Growth in the biologics market is mainly driven by monoclonal antibodies and human insulin, which are among the leading contributors to the bioprocess containers market. Additionally, the Centre for Biologics Evaluation and Research’s (CBER) (2021-25) strategic plan involves various schemes for boosting the growth of the biologics market.  Compared to traditional bio-manufacturing technologies, single-use systems (SUS) have many advantages, such as reduced requirements for process validation and higher manufacturing flexibility, which ultimately results in higher operating efficiency and reduced manufacturing costs.  Despite these advantages, there is a possibility that the plastic materials used for SUS may leach organic compounds or inorganic substances into the processing fluid or the final drug product, which remains a major concern. Such an undesired change could eventually compromise bioprocessing and might significantly impact the safety, quality, and purity of the drug product.   For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832 According to a survey conducted by BioPlan Associates in 2018, 73.3% of respondents agreed that leachables and extractables are major concerns that may limit the use of bioprocessing in the near future. As single-use assembly products are made of processed plastic materials, they often face the problem of contamination from the container due to leachables.  The patent expiry of blockbuster drugs has resulted in increased RD spending by pharmaceutical and biotechnology companies. Patent expiry of biologics leads to increasing RD of biologics and shifts biologics from the pipeline to commercial production. As the development and manufacturing costs of biologics are very high, companies are now gradually focusing on techniques that are more economical than traditional biomanufacturing methods.   Most single-use assemblies are made of multiple materials or layers, including polyethylene, polypropylene, ethylene vinyl alcohol, or nylon. Such products require extensive efforts to separate components into homogeneous components. As a result, most single-use assemblies and their components are not suited for recycling. This leads to the generation of large volumes of solid waste; its disposal is a challenging prospect for biopharmaceutical companies.  Recent Developments In June 2021, Avantor, Inc. (US) acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. This acquisition helped the company expand its bioproduction footprint in China. In April 2021, Sartorius Stedim Biotech (France) opened a new Customer Interaction Center (CIC) in Beijing, China, to expand its presence in China and to meet the high demand from the growing biopharmaceuticals market. In March 2021, Merck KGaA (Germany) invested ~USD 30 million (EUR 25 million) to add a single-use assembly production unit at its Life Science Center in Molsheim, France. With this expansion, the company is accelerating its European expansion plans for single-use technology, which is used for the production of COVID-19 vaccines and other lifesaving therapies.  Key Market Players The bioprocess containers market is dominated by a few globally established players such as Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany)